The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Dermatitis Herpetiformis (Gluten-Free Diet Management)

An intensely pruritic, papulovesicular eruption representing the cutaneous manifestation of celiac disease; granular IgA deposits at dermal papillae are diagnostic; lifelong gluten-free diet is the cornerstone treatment, with dapsone for rapid symptom control.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dermatoloji department. Book Appointment →

What is Dermatitis Herpetiformis (Gluten-Free Diet Management)?

Dermatitis herpetiformis (DH) is a chronic autoimmune blistering disease and the dermatologic manifestation of celiac disease, occurring in 10–20 percent of celiac patients. The cutaneous and intestinal manifestations are linked by a common immunologic mechanism: dietary gluten triggers production of IgA antibodies against tissue transglutaminase 2 (TG2, intestinal) and epidermal transglutaminase 3 (TG3, skin); IgA-TG3 immune complexes deposit at dermal papillae and trigger neutrophilic inflammation and subepidermal microabscesses leading to blister formation.

Epidemiology: prevalence 11.5 per 100,000 in Northern European populations (Finland highest), male predominance 1.5–2:1, peak onset 30–40 years (can occur in childhood and elderly); strong HLA association with HLA-DQ2 (90 percent) and HLA-DQ8 (5 percent), identical to celiac disease; family clustering common.

Clinical: symmetric grouped (herpetiform = clustered like herpes) papulovesicles, urticarial plaques, and excoriations because the intense pruritus often destroys vesicles before patients present (excoriations may be the only visible finding); classic distribution on extensor surfaces — elbows, knees, buttocks, sacrum, posterior neck, scalp, shoulders; mucosal involvement rare. Associated conditions: celiac disease (essentially universal subclinically — duodenal biopsy shows villous atrophy in 65–75 percent, partial in remainder), other autoimmune diseases (Hashimoto thyroiditis, type 1 diabetes, vitiligo, alopecia areata, pernicious anemia, Addison disease), enteropathy-associated T-cell lymphoma (rare but increased risk), small bowel adenocarcinoma. Diagnosis: skin biopsy from non-affected perilesional skin shows granular IgA deposits at the tips of dermal papillae on DIF (pathognomonic); H&E shows neutrophilic microabscesses at dermal papillae and subepidermal blisters; serology: IgA anti-TG2 (anti-tTG, screening), IgA anti-endomysial antibodies (EMA, confirmatory), IgA anti-deamidated gliadin peptides (DGP), IgA anti-TG3 (most specific for DH but less available); duodenal biopsy may be deferred if classic skin biopsy and positive serology.

Symptoms

Intense pruritus and burning, often disrupting sleep — pathognomonic feature
Symmetric grouped papules, vesicles (herpetiform), urticarial plaques
Excoriations are often the only visible finding (vesicles destroyed by scratching)
Extensor distribution: elbows, knees, buttocks, sacrum, posterior neck, scalp, shoulders
Hyperpigmentation in healed lesions (post-inflammatory)
Possible gastrointestinal symptoms of celiac (bloating, diarrhea, weight loss) but often absent
Iron deficiency anemia, vitamin and mineral deficiencies (subclinical malabsorption)
Symptoms worsen with gluten exposure and improve on strict gluten-free diet (over months)

Risk Factors

HLA-DQ2 (90 percent) or HLA-DQ8 (5 percent) — same as celiac disease
Northern European ancestry (Scandinavian highest)
Family history of celiac disease or DH
Personal or family history of autoimmune disease (thyroid, type 1 diabetes, vitiligo, alopecia areata, pernicious anemia)
Adult onset (peak 30–40 years; pediatric onset 7–10 years possible)
Male sex (1.5–2:1 male predominance)
Iodine exposure (may exacerbate flares)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Intensely itchy symmetric rash on elbows, knees, buttocks, scalp
  • Recurrent itchy blisters or excoriations destroyed before vesicle formation
  • Family history of celiac disease with skin symptoms
  • Suspected celiac with skin manifestation
  • Known DH with new gastrointestinal symptoms (lymphoma vigilance)
  • Pre-treatment dapsone screening (G6PD, CBC, LFT)
  • Anemia or nutritional deficiency with characteristic skin findings
  • Burning desire to scratch with no visible primary lesion (DH may present as excoriations only)

Treatment Methods

01
Diagnostic: perilesional skin biopsy (NOT lesional) for direct immunofluorescence — granular IgA at dermal papillae is pathognomonic; H&E lesional biopsy (neutrophilic microabscesses at dermal papillae, subepidermal blister); IgA anti-tTG (screening), IgA anti-EMA (confirmatory), total IgA (rule out IgA deficiency), IgA anti-TG3 if available; consider duodenal biopsy if any GI symptoms or atypical presentation
02
Lifelong strict gluten-free diet (GFD) is the cornerstone — eliminates dietary trigger, treats both skin and underlying enteropathy, may reduce risk of associated lymphoma; refer to dietitian experienced in celiac for education on hidden gluten sources, cross-contamination, certified gluten-free products; expect skin improvement over 6–24 months and ability to taper dapsone
03
Dapsone 50–200 mg daily for rapid pruritus relief (often within 24–48 hours, dramatic response is supportive of DH diagnosis); pre-screen G6PD; monitor CBC and reticulocyte count weekly for 4 weeks then monthly (hemolytic anemia, agranulocytosis), LFT, methemoglobin levels, peripheral neuropathy assessment
04
Alternative if dapsone intolerant or contraindicated: sulfapyridine 1–4 g daily (less hemolysis), sulfasalazine, sulfamethoxypyridazine, colchicine, tetracycline, niacinamide combination
05
Topical: high-potency corticosteroids (clobetasol propionate) for symptomatic itch and inflammation; emollients; topical antipruritics (menthol-camphor)
06
Antihistamines for nocturnal itch (sedating — hydroxyzine, diphenhydramine)
07
Avoid iodine excess (some patients have iodine sensitivity that exacerbates flares — minimize iodized salt, kelp, iodine-containing supplements)
08
Screen for and treat associated conditions: thyroid function, fasting glucose, vitamin D / B12 / iron / folate, bone densitometry; monitor for autoimmune comorbidities and lymphoma symptoms
09
Long-term follow-up: clinical response to GFD over months; reduce and discontinue dapsone over 1–2 years if disease quiescent on strict GFD; lifelong adherence to GFD is essential; intermittent gluten challenge causes recurrence within days to weeks

Which Department to Visit?

You can visit our Dermatoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dermatoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Eczema (Atopic Dermatitis)

Dermatoloji

Atopic dermatitis is a chronic skin disease commonly seen especially in children, flaring with genetic predisposition and environmental triggers.

Psoriasis

Dermatoloji

Psoriasis is an autoimmune disease in which skin cells proliferate rapidly when the immune system mistakenly attacks the skin, leading to thick scaly lesions.

Acne

Dermatoloji

Acne is a skin disease resulting from clogging of hair follicles with oil and dead skin cells, commonly seen in adolescence but can occur at any age.

Rosacea

Dermatoloji

Rosacea is a chronic inflammatory facial skin disease characterized by recurrent flushing, persistent erythema, telangiectasia, and inflammatory papules and pustules. Phymatous change and ocular involvement may complicate advanced disease.

Urticaria (Hives)

Dermatoloji

Urticaria is a skin condition with sudden pink-red wheals and intense itching that may follow an acute or chronic course.

Skin Fungal Infections

Dermatoloji

Skin fungal infections are common, contagious skin diseases caused by dermatophytes and yeast fungi colonizing the upper layers of the skin.

Hair Loss (Alopecia)

Dermatoloji

Alopecia is a general term for hair loss that can be genetic, hormonal, autoimmune, or nutritional; early intervention can slow progression.

Vitiligo

Dermatoloji

Vitiligo is an acquired autoimmune disease in which CD8+ T cells destroy melanocytes, producing well-demarcated depigmented patches. Early, sustained treatment can induce repigmentation and prevent progression; psychosocial impact warrants holistic care.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.